Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Monoclonal Antibody Approved for Stomach Bacterium

By LabMedica International staff writers
Posted on 27 Oct 2011
A monoclonal antibody that detects the bacterium Helicobacter pylori in gastric tissue biopsies is now officially available for pathologists.

The anti-H. More...
pylori Rabbit Monoclonal Primary Antibody (SP48) is designed to qualitatively detect the presence of the bacteria in formalin-fixed, paraffin-embedded (FFPE) gastric biopsy tissue via light microscopy.

Immunohistochemical staining with this antibody product may aid in the diagnosis of H. pylori infection. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls. This antibody is intended for in vitro diagnostic use.

The H. pylori antibody provides pathologists unprecedented views of the bacterium, allowing for a more accurate patient diagnosis. The high contrast staining of the organisms allows pathologists to view more bacteria than can be detected with special stains. A pathologist can clearly view the characteristic helical shape of the organism with the SP48 antibody. An infection can be detected and treated effectively even when very few organisms are present.

The antibody was developed by Ventana Medical Systems (Tucson, AZ, USA) and is fully integrated with the company’s BenchMark XT and BenchMark ULTRA slide staining instruments. The antibody has received 510(k) clearance from the US Food and Drug Administration (FDA, Silver Springs, MD, USA). Greg Yap, MBA, Ventana lifecycle leader for advanced staining assays, said, "FDA clearance of the VENTANA H. pylori antibody proves that our product surpasses the industry standard. By leveraging our expertise in industry-leading advanced staining assays and workflow solutions, we are delivering to pathologists another next-generation tool for treating potentially cancer-causing gastric infections.''

H. pylori infection is linked to chronic gastritis, ulcers, and stomach cancer. It is estimated that approximately two-thirds of the world's population harbors the H. pylori bacterium, which damages the mucous coating that protects the stomach and duodenum. This organism causes peptic ulcers in 9 out of 10 instances and studies have shown that those infected with it are nearly six times more likely to develop gastric cancer than those uninfected.

Related Links:

Ventana Medical Systems
US Food and Drug Administration




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Urinalysis Solution
UN-9000
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.